In its February 2025 issue, Neurotech Business Report publishes a profile of Synergia Medical, co-founded in 2014 by Attila Borbath and Pascal Doguet.
The article explains how the company's NAO technology replaces the metal enclosure and wiring of conventional implants with glass encapsulation and plastic optical fibres. This makes the device far less sensitive to electromagnetic interference, including in MRI scanners.
The first clinical application is vagus nerve stimulation for drug-resistant epilepsy, with an implant designed for a 15-year battery life and one minute of charging per day.